Add To Watchlist
Share URL
About The Company
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally.
Read More
Overview
Value
5
Growth
20
Health
47
Management
36
Analyst Opinion
69
Total
35
All Scores Out Of 100
Best Features
- Has a low level of debt
- Low risk of bankruptcy
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders
- No margin of safety at their current market price
- Poor earnings and cashflow growth 0
Latest News
Myriad Genetics' (MYGN) New Pact to Extend HRD Testing Access
Zacks Investment Research | 17:48 Fri 3 Mar 2023
Read More →
Larry Robbins' Firm Boosts 2 Health Care Stocks
GuruFocus | 22:35 Thu 2 Mar 2023
Read More →
Myriad Genetics (MYGN) Q4 Earnings Top, Gross Margin Falls
Zacks Investment Research | 17:02 Wed 1 Mar 2023
Read More →
Myriad Genetics, Inc. (MYGN) Q4 2022 Earnings Call Transcript
Seeking Alpha | 03:33 Wed 1 Mar 2023
Read More →
Market Peers
MYGN
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-65.47%
Revenue Growth (5 Year Average)
N/A
Ratings Consensus
Buy
Share Buybacks
-0.63%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
5
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 6.9 USD ✘
Current Price: 22.5 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-7.79%
PE/Earnings Growth
N/A
Price/Book
2.00x
Growth
Growth Score
20
- ✘ 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of N/A is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
N/A
Earnings Growth
N/A
Cashflow Growth
N/A
Health
Health Score
47
Altman Z Score
3.45
Piostroski Score
2.00
Debt/Equity
0.15x
Current Assets/Liabilities
2.65x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.39x
Management
Management Score
36
Average Buybacks/Dilution
-0.63%
Recent Buybacks/Dilution
0.65%
5 Year Price Volitility
31.80%
Return On Assets
-2.88%
Return On Capital Employed
-1.28%
Return On Equity
-3.81%
Return On Free Cashflow
61.27%
Return On Investments
-23.52%
Analysts
Analyst Opinion
69
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Myriad Genetics, Inc.
Currency
USD
Beta
1.755842
Vol Avg
750967
Ceo
Mr. R. Bryan Riggsbee
Cik
0000899923
Cusip
62855J104
Exchange
NASDAQ Global Select
Full Time Employees
2400
Industry
Diagnostics & Research
Sector
Healthcare
Ipo Date
1995-10-06
Address
320 S Wakara Way
City
Salt Lake City
State
UTAH
Country
US
Zip
84108
Phone
18015843600
All financial data provided by FMP